Some cookies are essential to the running of the website, while others (analytics) help us to make improvements. We also incorporate functionality from other websites, such as video, social media feeds and Browsealoud (text-to-speech and translations services) which may set cookies. More on how we use cookies
This website uses text-to-speech software called Browsealoud to read and / or translate its content . To use Browsealoud, you must allow Browsealoud cookies; the Browsealoud icon will then appear at the bottom right of your screen.
You can find out more about how Browsealoud uses cookies or change your cookie preferences at any time by going to our cookies page.
Allow Browsealoud cookies Do not use Browsealoud
If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).
Please find information on our services and visiting restrictions in our COVID-19 section.
Patients and visitors must wear a face covering in our hospitals.
This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.
There are pharmacy dispensaries at three hospitals within the Trust. These dispense medicines to patients for use on the wards and to take home (TTO) when they are discharged from hospital. They also dispense medicines for outpatients.
All medicines are currently included in the Trust's medicines formulary (a list of medicines approved for use within the Trust).
Oxford University Hospitals Formulary July 2021 (pdf, 2 MB)
The dispensary is in the corridor from the main entrance on Level 2 of the John Radcliffe Hospital.
The dispensary is by the East Entrance of the Churchill Hospital (Car Park 4). You do not have to go in to the main building.
The dispensary is located by the Oxford Road entrance of the Horton General Hospital. Enter through the Outpatient entrance sliding doors and turn right; it is a short distance along on the right hand side.
B-Cell repopulation after Ocrelizumab in Multiple Sclerosis Patients (4858)
Cefazolin as second line treatment for invasive Methicillin-Susceptible Staphylococcus aureus infection in a UK cohort of patients
Efficacy and tolerability of VCD chemotherapy in a UK real-world dataset of elderly transplant-ineligible newly diagnosed myeloma patients
The standards treatment
A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care. Seizure: European Journal of Epilepsy 75 (2020) 153-164
Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: Challenges and measurable outcomes
Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of care
Myeloma clinical outcomes following the first wave of COVID-19: results from the Thames Valley Cancer Alliance (UK)
Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review (pdf)
Co-administration of multiple intravenous medicines: Intensive care nurses' views and perspectives
Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU